Remodulin
Brand names,
Remodulin
Analogs
Remodulin
Brand Names Mixture
Remodulin
Chemical_Formula
C66H75Cl2N9O24
Remodulin
RX_link
http://www.rxlist.com/cgi/generic2/vancomycin.htm
Remodulin
fda sheet
Remodulin
msds (material safety sheet)
Remodulin
Synthesis Reference
No information avaliable
Remodulin
Molecular Weight
1449.25 g/mol
Remodulin
Melting Point
No information avaliable
Remodulin
H2O Solubility
No information avaliable
Remodulin
State
Solid
Remodulin
LogP
-0.47
Remodulin
Dosage Forms
Capsules; Nonpyrogenic premixed 100 mL or 200 mL solution containing 500 mg or 1 g vancomycin for injection
Remodulin
Indication
For the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci.
Remodulin
Pharmacology
Vancomycin is a branched tricyclic glycosylated nonribosomal peptide produced by the fermentation of the Actinobacteria species Amycolatopsis orientalis (formerly Nocardia orientalis). It is often reserved as the "drug of last resort", used only after treatment with other antibiotics had failed. Vancomycin has been shown to be active against most strains of the following microorganisms, both in vitro and in clinical infections: Listeria monocytogenes, Streptococcus pyogenes, Streptococcus pneumoniae (including penicillin-resistant strains), Streptococcus agalactiae, Actinomyces species, and Lactobacillus species. The combination of vancomycin and an aminoglycoside acts synergistically in vitro against many strains of Staphylococcus aureus, Streptococcus bovis, enterococci, and the viridans group streptococci.
Remodulin
Absorption
Poorly absorbed from gastrointestinal tract, however systemic absorption (up to 60%) may occur following intraperitoneal administration.
Remodulin
side effects and Toxicity
The oral LD50 in mice is 5000 mg/kg. The median lethal intravenous dose is 319 mg/kg in rats and 400 mg/kg in mice.
Remodulin
Patient Information
Remodulin
Organisms Affected
Enteric bacteria and other eubacteria